Tango Therapeutics, Inc. - Common Stock, $0.001 par value per share (TNGX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
TNGX on Nasdaq
Shares outstanding
133,858,590
Price per share
$11.75
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
65,776,312
Total reported value
$582,697,841
% of total 13F portfolios
0%
Share change
+9,630,444
Value change
+$87,647,602
Number of holders
102
Price from insider filings
$11.75
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tango Therapeutics, Inc. - Common Stock, $0.001 par value per share (TNGX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FARALLON PARTNERS L L C/CA 10% $119,266,365 13,461,215 Dapice Joshua J. 31 Dec 2025
Farallon Capital Partners, L.P. 9.7% +16% $90,358,800 +$13,440,000 10,757,000 +17% Dapice Joshua J. 30 Sep 2025
EcoR1 Capital, LLC 9.9% $15,520,875 10,630,736 EcoR1 Capital, LLC 31 Dec 2024
Adage Capital Management, L.P. 7.9% +281% $124,643,107 +$95,138,857 10,607,924 +322% Adage Capital Management, L.P. 31 Dec 2025
TCG Crossover GP II, LLC 6.3% $71,704,046 8,536,196 TCG Crossover GP II, LLC 30 Sep 2025
BlackRock, Inc. 6.3% +26% $75,107,682 +$26,758,396 8,477,165 +55% BlackRock, Inc. 31 Dec 2025
Invus Global Management, LLC 6.1% +16% $95,943,144 +$26,815,686 8,165,374 +39% Raymond Debbane 31 Dec 2025
VANGUARD GROUP INC 5% $59,813,656 6,750,977 The Vanguard Group 31 Dec 2025
Third Rock Ventures IV, L.P. 4.7% -18% $74,901,244 -$17,625,000 6,374,574 -19% Third Rock Ventures IV, L.P. 06 Feb 2026
Woodline Partners LP 5.6% $35,757,343 6,029,906 Woodline Partners LP 30 Jun 2025
FMR LLC 0% $19,552 13,392 FMR LLC 29 Nov 2024

As of 31 Dec 2025, 102 institutional investors reported holding 65,776,312 shares of Tango Therapeutics, Inc. - Common Stock, $0.001 par value per share (TNGX). This represents 49% of the company’s total 133,858,590 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Tango Therapeutics, Inc. - Common Stock, $0.001 par value per share (TNGX) together control 47% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 6.4% 8,540,797 +51% 0% $75,671,463
Siren, L.L.C. 6.1% 8,165,374 +39% 2.2% $72,345,214
TRV GP IV, LLC 5.9% 7,874,574 -43% 27% $69,768,726
VANGUARD GROUP INC 5% 6,750,977 +34% 0% $59,813,655
STATE STREET CORP 4.6% 6,218,567 +85% 0% $55,096,504
GOLDMAN SACHS GROUP INC 3.7% 4,942,414 +227% 0.01% $43,789,788
Nantahala Capital Management, LLC 2.7% 3,572,633 +97% 1.9% $31,653,528
GEODE CAPITAL MANAGEMENT, LLC 1.9% 2,553,656 +36% 0% $22,629,824
Deep Track Capital, LP 1.8% 2,454,562 +69% 0.5% $21,747,419
Vivo Capital, LLC 1.6% 2,154,780 +177% 1.2% $19,091,351
MORGAN STANLEY 1.1% 1,421,794 +465% 0% $12,597,094
FRANKLIN RESOURCES INC 1% 1,398,057 +51% 0% $12,386,785
Affinity Asset Advisors, LLC 0.75% 1,000,000 0.64% $8,860,000
UBS Group AG 0.74% 990,458 +517% 0% $8,775,458
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.63% 840,992 +28% 0% $7,451,189
Candriam S.C.A. 0.53% 708,812 0% 0.03% $6,280,342
BESSEMER GROUP INC 0.53% 708,398 0% 0.01% $6,276,000
DIMENSIONAL FUND ADVISORS LP 0.36% 487,076 -28% 0% $4,315,493
BARCLAYS PLC 0.28% 368,187 +0.69% 0% $3,262,136
Mass General Brigham, Inc 0.26% 354,192 0% 0.39% $3,138,141
Bank of New York Mellon Corp 0.26% 343,840 +79% 0% $3,046,426
MARSHALL WACE, LLP 0.25% 329,231 -78% 0% $2,916,987
Nuveen, LLC 0.22% 300,441 -68% 0% $2,661,907
GREAT LAKES ADVISORS, LLC 0.22% 294,303 -31% 0.02% $2,607,525
CONGRESS ASSET MANAGEMENT CO 0.18% 234,628 +2.9% 0.01% $2,078,804

Institutional Holders of Tango Therapeutics, Inc. - Common Stock, $0.001 par value per share (TNGX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 65,776,312 $582,697,841 +$87,647,602 $8.86 102
2025 Q3 139,978,941 $1,175,803,271 +$109,407,056 $8.40 141
2025 Q2 127,196,008 $651,244,300 +$113,427,538 $5.12 114
2025 Q1 107,228,944 $146,966,295 -$1,500,604 $1.37 119
2024 Q4 106,381,203 $328,721,243 -$120,601,739 $3.09 134
2024 Q3 101,459,260 $781,203,088 -$3,564,439 $7.70 119
2024 Q2 98,595,824 $845,901,469 +$2,628,498 $8.58 116
2024 Q1 98,377,909 $781,109,580 +$30,778,538 $7.94 124
2023 Q4 93,643,916 $927,104,831 +$41,143,001 $9.90 118
2023 Q3 88,799,639 $999,861,944 +$236,872,193 $11.26 99
2023 Q2 68,320,832 $226,845,382 -$7,737,842 $3.32 89
2023 Q1 69,836,747 $275,851,159 +$1,770,332 $3.95 91
2022 Q4 68,766,073 $498,554,976 +$12,927,727 $7.25 83
2022 Q3 68,157,717 $246,729,459 -$12,119,590 $3.62 86
2022 Q2 70,452,006 $319,137,805 -$11,072,751 $4.53 76
2022 Q1 69,679,958 $528,174,476 +$13,385,662 $7.58 70
2021 Q4 67,775,150 $740,996,532 +$24,899,642 $10.94 57
2021 Q3 65,465,348 $844,863,000 +$844,863,000 $12.93 45